Aplastic anemia has been linked to environmental exposures, from chemicals and medical drugs to infectious agents. The disease occurs more frequently in Asia than in the West, with incidence rates 2- to 3-fold higher. We report updated results of an epidemiologic study conducted in Thailand from 1989 to 2002, in which 541 patients and 2261 controls were enrolled. Exposures were determined by in-person interview. We observed significantly elevated relative risk estimates for benzene (3.5) and other solvents (2.0) and for sulfonamides (5.6), thiazides (3.8), and mebendazole (3.0). Chloramphenicol use was infrequent, and no significant association was observed. Agricultural pesticides were implicated in Khonkaen (northeastern Thailand). There were significant associations with organophosphates (2.1), DDT (6.7), and carbamates (7.4). We found significant risks for farmers exposed to ducks and geese (3.7) and a borderline association with animal fertilizer (2.1). There was a significant association in Khonkaen with drinking other than bottled or distilled water (2.8). Nonmedical needle exposure was associated in Bangkok and Khonkaen combined (3.8). Most striking was the large etiologic fraction in a rural region accounted for by animal exposures and drinking of water from sources such as wells, rural taps, and rainwater, consistent with an infectious etiology for many cases of aplastic anemia in Thailand.

Aplastic anemia (AA) is defined as pancytopenia accompanied by a hypocellular bone marrow.1  Laboratory and clinical observations have implicated an immunologic pathophysiology. As with other autoimmune diseases, both environmental triggers and individual host factors are hypothesized to determine risk. AA has long been linked to exposure to benzene, pesticides, and other chemicals.2  Marrow failure is a severe idiosyncratic complication of the use of certain medical drugs, most infamously chloramphenicol.2  It can follow specific viral infections, as in postseronegative hepatitis,3  and it is a rare complication of pregnancy.4  Clusters of AA have been reported.5-8  Nevertheless, mechanisms linking environmental triggers to bone marrow failure are poorly defined, and most cases are labeled idiopathic.

While rare in the United States and Europe, AA occurs more frequently elsewhere. Early Western observers were struck by the large numbers of cases they observed in Asian clinics.9,10  Japanese hematologists have commented on AA as an unusual diagnosis in Europe and the United States.11  Large numbers of AA cases have been reported from single hospitals in China,12  Korea,13  Thailand,14  and elsewhere in Asia.15-19  Early estimates suggest that AA was at least 4- to 5-fold more common in the East20,21 ; autopsy diagnoses were 3-fold higher in Japan compared to Europe and the United States.22  An extraordinarily high prevalence was reported for specific locations (the Mudanjiang region of China23 ) and in certain populations (industrial workers in Japan24 ). Exposure to toxic chemicals was implicated; other potential culprits were hepatitis and common, casual administration of the antibiotic chloramphenicol.25 

Starting in the late 1980s, we undertook a systematic epidemiologic study of AA in Thailand to determine a precise incidence rate and risk factors, reasoning that etiologic environmental exposures could be more easily identified where the disease was prevalent. Using an active case-ascertainment strategy based on previous experience conducting the International Agranulocytosis and Aplastic Anemia Study (IAAAS) in Europe and Israel26  and concentrating on metropolitan Bangkok and the 2 rural regions of Songkla and Khonkaen, we found that AA was 2- to 3-fold more frequent in these areas of Thailand than in the West.27,28  A questionnaire was employed to identify differences in recent environmental histories between aplastic anemia patients and a comparative series of other hospital patients selected to be representative of the entire population. Prominent reported findings from the early phase of the study included surprising associations of AA with poverty29  and rice farming30  and with agricultural30  but not household31  pesticide use. There was also a low proportion of cases in which medical drug use could be implicated.32  As risk factors were identified or discarded based on these results, the geographic compass of the study and the focus of the questionnaire were refined. We here report final results obtained from the Thai study—the largest collection of AA cases ever subjected to systematic analysis—with particular emphasis on more recently collected information.

A case-control study was carried out in 2 phases: from February 1989 to December 1994 (phase 1), and from January 1995 to March 2002 (phase 2). Protocols were approved by institutional review boards of Mahidol University, Khonkaen University, Prince of Songkla University, the National Heart, Lung, and Blood Institute, and Boston University. All patients and controls provided informed consent according to the Declaration of Helsinki.

Phase 1

The study commenced in Bangkok (including the city and the suburbs of Nonthaburi, Nakornpathom, Patumthani, Samutprakarn, and Samutsakorn: total population approximately 8.75 million) in February 1989. In November 1991, it was expanded to the Khonkaen region in northeastern Thailand (Khonkaen, Kalasin, Mahasarakam, Loei, Nongkai, Udonthani, and Royed: 7.64 million) and to the Songkla region in the south (Songkla, Yala, Pattani, Satoon, Nakornsrithammarat, and Trang: 4.99 million). The study was population based in all participating centers.27 

In each region, potential cases were identified by regular contact with hematologists or other physicians either by telephone or visit at least every other week. Eligible subjects were required to meet at least 2 of the following criteria: white blood cell count 3.5 × 109/L, platelet count equal to or less than 50 × 109/L, and either hemoglobin concentration equal to or less than 100 g/L or hematocrit equal to or less than .30 (30%). If the latter criterion was 1 of 2 fulfilled, a reticulocyte count equal to or less than 30 × 109/L also was required. Patients who received chemotherapy, immunotherapy, or radiotherapy were excluded. Fanconi anemia also was excluded, based on family history and the presence of typical physical characteristics. The definitive diagnosis and final acceptance of cases also required a characteristic bone marrow biopsy showing hypocellularity without fibrosis or infiltration by leukemic, lymphomatous, or carcinoma cells. The biopsies were reviewed by study hematologists without knowledge of exposures to determine final eligibility.

Controls were selected from among other hospital patients and matched to potential cases for age (younger than 2, 2-5, 6-14, 15-24, 25-44, 45-64, and at least 65 years) and sex in an approximate ratio of 4:1. To maximize the number of controls, those matched to excluded potential cases were retained in the analysis. To be eligible, controls had to have admission diagnoses judged to be independent of drug use or occupational exposure. Acceptable diagnoses included trauma, acute infections (eg, pneumonia), acute abdominal emergencies (such as appendicitis), and other selected conditions (eg, cataract surgery). As with cases, patients who had received chemotherapy, immunotherapy, or radiotherapy were excluded.

All subjects were interviewed by trained study personnel who were physicians or nurses, and all interviewers enrolled both cases and controls. The information included demographic data; relevant medical history; detailed history of drug use (including herbal preparations), focusing especially on the 6 months before admission; history of pesticide use, again with emphasis on the 6 months before admission; and history of exposure to chemicals or radiation. There were no refusals to participate among the potential cases and controls. All cases were included in the estimation of incidence rates, but some were too ill to be interviewed. A total of 374 cases were identified, of which 284 were interviewed, including 160 in Bangkok, 81 in Khonkaen, and 43 in Songkla. Interviewed cases were somewhat younger (37% under the age of 25) and more likely to be male (53%) than those who were not interviewed (29% and 48%, respectively). There were 1174 controls (Bangkok, 698; Khonkaen, 295; Songkla, 181). The diagnostic distribution of the controls included 310 (26%) with trauma, 232 (20%) with acute infections, 257 (22%) with abdominal emergencies, and 375 (32%) with other diagnoses.

Phase 2

In phase 2, data collection was expanded or modified to pursue in greater detail potential leads identified in phase 1. However, care was taken to ensure that the data from the 2 phases could, when appropriate, be combined. For practical reasons Songkla was no longer included as a study center, and in Bangkok data collection was restricted to one hospital (Siriraj). In Khonkaen the hospital network remained unchanged; thus, the study encompassed the full population of that region during phase 2.

During phase 2, greater detail on occupational and household exposure to solvents and other chemicals and on recent job history was recorded. Data collection also was expanded to obtain information relevant to a possible infectious etiology, as suggested by results of phase 1, including the nonmedical use of needles, sanitary facilities, source of drinking water, and farming practices; the latter included the crops farmed and farming methods. In 1998 further questions were added to obtain information on exposure to farm animals and fertilizers.

A total of 257 cases was enrolled, 77 in Bangkok and 180 in Khonkaen. There were 1087 controls (317 and 770, respectively), with a diagnostic distribution of 505 (46%) with trauma, 218 (20%) with acute infections, 190 (18%) with abdominal emergencies, and 174 (16%) with other diagnoses.

Data analysis

Relative risks (odds ratios) were estimated by unconditional logistic regression33  to control confounding. Crude relative risk estimates also are provided for all comparisons, but unless otherwise specified the multivariate estimates are referred to in describing results. Different models were used in various subanalyses, as described later in this section. As a check on the homogeneity of the controls, sensitivity analyses also were conducted, in which major categories of controls were excluded in turn from the multivariate models evaluating the main risk factors. The results generally were consistent with those based on all the controls, and only the latter are reported.

Results concerning drug use have been reported previously, based on phase 1 data.32  To update those findings, the combined data from the entire study were used, including 541 cases and 2261 controls. For the analysis of solvent exposures the data also were combined. Factors included in the models for these analyses were the matching variables (age, sex, and region), year of interview (as a continuous variable), and the use of drugs, solvents, and occupational and household pesticides (the latter for control of confounding only).

For all other factors, data analysis was confined to phase 2. This included factors previously reported and now evaluated further (income29  and pesticides31 ) and newly explored potential risk factors (farming, exposure to farm animals, fertilizer use, consumption of raw fish and crabs, nonmedical needle exposures, sanitation, and drinking water). Risks for needle exposures were estimated based on the total phase 2 dataset of 257 cases and 1087 controls, with the following additional factors in the model: age, sex, region, year of interview (as a continuous variable), and occupational and household pesticide use. Risks according to income and source of drinking water in Bangkok were estimated based on 77 phase 2 cases and 317 controls, from models which included age, sex, and year of interview in addition to the specific factors under consideration.

There were more factors under consideration in the Khonkaen phase 2 analyses of 180 cases and 770 controls (pesticides, other farming variables, sources of drinking water, and income), and the models were correspondingly more complex. In addition to the specific factor(s) under consideration, the models included age, sex, year of interview (as a continuous variable), residential location within the Khonkaen region (4 categories of urban and rural areas), occupational and household pesticide use, exposure to ducks or geese, use of animal fertilizers, and consumption of nonbottled water.

Etiologic fractions representing the proportion of the disease attributable to exposure were calculated for significantly associated factors.34 

Demographic characteristics (total study data)

Age and sex distributions of cases and controls were similar in each of the 3 regions due to matching (Table 1). There were slightly more males than females among the cases in Bangkok, an even split in Khonkaen, and a preponderance of females in Songkla (with a much smaller total number). The cases from Bangkok were younger: median age was 26 years, compared with 43 years in Khonkaen and 57 years in Songkla.

Table 1.

Distribution of 541 cases of aplastic anemia and 2261 controls by region according to age and sex



Cases

Controls

No.
%
No.
%
Bangkok (237 cases, 1015 controls)     
   Age younger than 25 years   103   43   418   41  
   Age 25 to 39 years   64   27   258   25  
   Age 40 to 59 years   42   18   179   18  
   Age at least 60 years   28   12   160   16  
   Male   126   53   527   52  
   Female   111   47   488   48  
Khonkaen (261 cases, 1065 controls)     
   Age younger than 25 years   41   16   173   16  
   Age 25 to 39 years   73   28   322   30  
   Age 40 to 59 years   99   38   402   38  
   Age at least 60 years   48   18   168   16  
   Male   129   49   544   51  
   Female   132   51   521   49  
Songkla (43 cases, 181 controls)     
   Age younger than 25 years   9   21   33   18  
   Age 25 to 39 years   4   9   27   15  
   Age 40 to 59 years   10   23   41   23  
   Age at least 60 years   20   47   80   44  
   Male   17   40   90   50  
   Female
 
26
 
60
 
91
 
50
 


Cases

Controls

No.
%
No.
%
Bangkok (237 cases, 1015 controls)     
   Age younger than 25 years   103   43   418   41  
   Age 25 to 39 years   64   27   258   25  
   Age 40 to 59 years   42   18   179   18  
   Age at least 60 years   28   12   160   16  
   Male   126   53   527   52  
   Female   111   47   488   48  
Khonkaen (261 cases, 1065 controls)     
   Age younger than 25 years   41   16   173   16  
   Age 25 to 39 years   73   28   322   30  
   Age 40 to 59 years   99   38   402   38  
   Age at least 60 years   48   18   168   16  
   Male   129   49   544   51  
   Female   132   51   521   49  
Songkla (43 cases, 181 controls)     
   Age younger than 25 years   9   21   33   18  
   Age 25 to 39 years   4   9   27   15  
   Age 40 to 59 years   10   23   41   23  
   Age at least 60 years   20   47   80   44  
   Male   17   40   90   50  
   Female
 
26
 
60
 
91
 
50
 

Socioeconomic status (phase 2)

Self-reported per capita household income was used as an index of socioeconomic status. In an earlier finding from phase 1 of the study, we reported an inverse association of income with increasing relative risk of AA.29  In the more recent sample from phase 2, this association was no longer observed either in Bangkok or in Khonkaen (Table 2). For the lowest income group (< 1000 baht/mo, adjusted for inflation to 1989 baht to be comparable with the phase 1 results) in Khonkaen, a crude relative risk estimate of 2.1 was reduced by multivariate adjustment to 1.1; the main factors accounting for the reduction were residential location and consumption of nonbottled water.

Table 2.

Per capita household income among 257 cases of aplastic anemia and 1087 controls according to region (phase 2 data only)



Cases

Controls

Relative risk estimate
Per capita income, baht/mo*
No.
%
No.
%
Crude
Multivariate (95% CI)
Bangkok; 77 cases, 317 controls       
   At least 5000   40   52   131   41   1.0  1.0 
   2500 to 4999   19   25   110   35   0.6   0.6 (0.3-1.0)  
   1000 to 2499   15   19   52   16   0.9   1.0 (0.5-1.9)  
   Less than 1000   2   3   15   5   0.5   0.5 (0.1-2.2)  
   Unknown   1   1   9   3   —   —  
Khonkaen; 180 cases, 770 controls       
   At least 5000   19   11   93   12   1.0  1.0 
   2500 to 4999   30   17   137   18   1.1   0.8 (0.4-1.5)  
   1000 to 2499   68   38   394   51   0.8   0.4 (0.2-0.7)  
   Less than 1000   62   34   146   19   2.1   1.1 (0.6-2.1)  
   Unknown
 
1
 
0.6
 
0
 
0
 

 

 


Cases

Controls

Relative risk estimate
Per capita income, baht/mo*
No.
%
No.
%
Crude
Multivariate (95% CI)
Bangkok; 77 cases, 317 controls       
   At least 5000   40   52   131   41   1.0  1.0 
   2500 to 4999   19   25   110   35   0.6   0.6 (0.3-1.0)  
   1000 to 2499   15   19   52   16   0.9   1.0 (0.5-1.9)  
   Less than 1000   2   3   15   5   0.5   0.5 (0.1-2.2)  
   Unknown   1   1   9   3   —   —  
Khonkaen; 180 cases, 770 controls       
   At least 5000   19   11   93   12   1.0  1.0 
   2500 to 4999   30   17   137   18   1.1   0.8 (0.4-1.5)  
   1000 to 2499   68   38   394   51   0.8   0.4 (0.2-0.7)  
   Less than 1000   62   34   146   19   2.1   1.1 (0.6-2.1)  
   Unknown
 
1
 
0.6
 
0
 
0
 

 

 

—indicates not calculated.

*

Adjusted for inflation to 1989 baht

The following factors were included in the models: Bangkok: age, sex, year of interview (continuous term), consumption of nonbottled water, income; Khonkaen: age, sex, residential location, year of interview (continuous term), pesticide use, exposure to ducks, animal fertilizer use, consumption of nonbottled water, income

Reference category

Benzene and other solvents (total study data)

For benzene the overall relative risk estimate was 3.5 (95% CI, 1.2-10), and for cumulative exposure of at least 4 days, it was 3.2 (1.0-11) (Table 3). For fuels (kerosene, gasoline, fuel oil, and diesel fuel) and glues, there were no associations. For other solvents, mostly unspecified thinners, the overall estimate of 2.0 was significantly elevated, and for at least 4 days of total exposure the estimate was 1.9 (1.2-2.8). Turpentine was the specific chemical most often identified (phase 2 only): while the overall prevalence was higher among cases (5% vs 2%), the prevalence of at least 4 days' exposure was similar (1% vs 1%).

Table 3.

Solvent exposure among 541 cases of aplastic anemia and 2261 controls



Cases

Controls

Relative risk estimate
Solvent*
No.
%
No.
%
Crude
Multivariate(95% CI)
Benzene  7   1   8   0.3   3.7  3.5 (1.2-10)  
   At least 4 days' total exposure   5   1   7   0.3   3.0   3.2 (1.0-11)  
Fuels§  11   2   49   2   0.9   1.0 (0.5-2.0)  
   At least 4 days' total exposure   9   2   47   2   0.8   0.8 (0.4-1.8)  
Glues  39   7   128   6   1.3   1.2 (0.7-1.8)  
   At least 4 days' total exposure   23   4   83   4   1.2   1.0 (0.6-1.7)  
Other solvents  58   11   140   6   1.8  2.0 (1.4-2.8)  
   At least 4 days' total exposure
 
40
 
7
 
106
 
5
 
1.7
 
1.9 (1.2-2.8)
 


Cases

Controls

Relative risk estimate
Solvent*
No.
%
No.
%
Crude
Multivariate(95% CI)
Benzene  7   1   8   0.3   3.7  3.5 (1.2-10)  
   At least 4 days' total exposure   5   1   7   0.3   3.0   3.2 (1.0-11)  
Fuels§  11   2   49   2   0.9   1.0 (0.5-2.0)  
   At least 4 days' total exposure   9   2   47   2   0.8   0.8 (0.4-1.8)  
Glues  39   7   128   6   1.3   1.2 (0.7-1.8)  
   At least 4 days' total exposure   23   4   83   4   1.2   1.0 (0.6-1.7)  
Other solvents  58   11   140   6   1.8  2.0 (1.4-2.8)  
   At least 4 days' total exposure
 
40
 
7
 
106
 
5
 
1.7
 
1.9 (1.2-2.8)
 
*

Use in the year before admission. Categories not mutually exclusive

Relative to nonexposure to the solvent under consideration

The following factors were included in the model: age, sex, region, year of interview, solvent exposure, pesticide use, drug use. Statistically significant estimates are italicized

§

Kerosene (7 cases, 23 controls), gasoline (5 cases, 24 controls), fuel oil (1, 2), diesel fuel (0, 4)

Tra chang glue (22 cases, 75 controls), rubber glue (3, 15), leather shoe glue (1, 6), PVC blue (0, 7), polyvinyl acetate (0, 2), epoxy (0, 2), unspecified glue (13, 26). Type of glue was not recorded in phase 1; identified nonsolvent-based glues were not included in the phase 2 portion of the data. A total of 33 cases and 123 controls were exposed to solvent-based glues in phase 2 (crude relative risk estimate, 1.2)

Turpentine (12 cases, 24 controls: reported in phase 2 only), naphtha (2, 0), paint remover (1, 0), 3A thinner (0, 6), alcohol (1, 7), toluene (1, 1), methylethylketone (1, 0), dry-cleaning solvent (0, 2), unspecified thinner (43, 111), unspecified solvent (5, 12)

Medical drugs (total study data)

We previously reported that the proportion of AA that could be attributed to drug use in Thailand was low.32  In the full study data, there were few exposures to chloramphenicol; the relative risk estimate of 1.8 was not statistically significant (Table 4), although the upper confidence limit was 6.5. For sulfonamides (all taken as anti-infectives), the estimate was 5.6 (1.4-22). For mebendazole and thiazides, the estimates were 3.0 (1.2-7.8) and 3.8 (1.6-9.4), respectively. For nonsteroidal anti-inflammatory drugs (NSAIDs), the relative risk estimate was 1.6 and nonsignificant. No other associations were uncovered in the combined data (results not shown). There were no reported exposures to gold or penicillamine.

Table 4.

Drug exposure in days 29 to 180 among 541 cases of aplastic anemia and 2261 controls



Cases

Controls

Relative risk estimate*

Drug
No.
%
No.
%
Crude
Multivariate(95% CI)
Original relative risk estimate
Chloramphenicol   4   0.7   8   0.4   2.1   1.8 (0.5-6.5)   2.7 (0.7-10)  
Sulfonamides   5   1   4   0.2   5.3  5.6 (1.4-22)  7.9 
Tetracyclines   10   2   23   1   1.8   1.6 (0.7-3.4)   1.8 (0.6-5.6)  
Mebendazole   8   1   10   0.4   3.4  3.0 (1.2-7.8)  6.3 
Thiazide diuretics   10   2   11   0.5   3.9  3.8 (1.6-9.4)  7.7 (1.5-40)  
NSAIDs
 
9
 
2
 
20
 
1
 
1.9
 
1.6 (0.7-3.8)
 
Not reported
 


Cases

Controls

Relative risk estimate*

Drug
No.
%
No.
%
Crude
Multivariate(95% CI)
Original relative risk estimate
Chloramphenicol   4   0.7   8   0.4   2.1   1.8 (0.5-6.5)   2.7 (0.7-10)  
Sulfonamides   5   1   4   0.2   5.3  5.6 (1.4-22)  7.9 
Tetracyclines   10   2   23   1   1.8   1.6 (0.7-3.4)   1.8 (0.6-5.6)  
Mebendazole   8   1   10   0.4   3.4  3.0 (1.2-7.8)  6.3 
Thiazide diuretics   10   2   11   0.5   3.9  3.8 (1.6-9.4)  7.7 (1.5-40)  
NSAIDs
 
9
 
2
 
20
 
1
 
1.9
 
1.6 (0.7-3.8)
 
Not reported
 
*

Relative to nonexposure to the drug under consideration

The following factors were included in the model: age, sex, region, year of interview, solvent exposure, pesticide use, drug use. Statistically significant estimates are italicized

“Original relative risk estimates” are taken from the previously published findings of phase 142 

Crude estimate with P < .05; the confidence interval was not provided

Pesticides (phase 2, Khonkaen)

An emphasis in phase 2 was agricultural exposures. For their evaluation, the analysis was confined to Khonkaen, a predominantly rural area. We previously reported that, with the possible exception of insecticides in the carbamate class, household pesticide use does not increase the risk of AA,31  and the phase 2 data from Khonkaen confirmed this lack of association (Table 5). Specifically for household carbamates, there were 27 exposed cases (15%) and 115 exposed controls (15%). Risks were elevated for several different classes of agricultural pesticides. Overall, for organophosphates, the relative risk estimate was 2.1 (1.1-4.2), comparable to the results from phase 1.30  For DDT, based on small numbers, the estimate was 6.7 (1.5-30). For carbamates, the estimate was 7.4 (1.7-31), but there were only 3 exposed controls. For paraquat, an herbicide, the relative risk estimate was 2.3 (1.0-5.1). For the combined category of other occupational pesticides, there was no association. Subanalyses for each group of agricultural pesticides were conducted according to cumulative exposure and whether the pesticide was applied by the subject. The relative risk estimate for organophosphates was somewhat higher than the overall estimate when the compounds were applied by the subject (2.9). For cumulative exposure of at least 4 days, the estimate was similar to the overall (2.1). For DDT and carbamates, most exposures were in the “heavier” categories.

Table 5.

Pesticide use among 180 cases of aplastic anemia and 770 controls in Khonkaen (phase 2 data only)



Cases

Controls

Relative risk estimate*
Pesticide
No.
%
No.
%
Crude
Multivariate(95% CI)
Organophosphates  21   12   32   4   3.0  2.1 (1.1-4.2)  
   Applied by subject   15   8   16   2   4.4  2.9 (1.3-6.9)  
   At least 4 days' total exposure   17   9   26   3   3.0   2.1 (1.0-4.4)  
DDT  5   3   4   0.5   5.5  6.7 (1.5-30)  
   Applied by subject   5   3   4   0.5   5.5   —  
   At least 4 days' total exposure   5   3   4   0.5   5.5   —  
Carbamates§  8   4   3   0.4   12  7.4 (1.7-31)  
   Applied by subject   7   4   2   0.3   —   —  
   At least 4 days' total exposure   6   3   1   0.1   —   —  
Paraquat  12   7   24   3   2.2   2.3 (1.0-5.1)  
   Applied by subject   7   4   17   2   1.8   1.7 (0.6-4.7)  
   At least 4 days' total exposure   7   4   20   3   1.6   1.9 (0.7-4.9)  
Other occupational pesticides  11   6   32   4   1.5   1.0 (0.4-2.2)  
   Applied by subject   6   3   18   2   1.5   0.7 (0.2-2.2)  
   At least 4 days' total exposure   9   5   24   3   1.6   1.1 (0.4-2.7)  
Any household pesticides
 
64
 
36
 
238
 
31
 
1.2
 
1.3 (0.9-1.9)
 


Cases

Controls

Relative risk estimate*
Pesticide
No.
%
No.
%
Crude
Multivariate(95% CI)
Organophosphates  21   12   32   4   3.0  2.1 (1.1-4.2)  
   Applied by subject   15   8   16   2   4.4  2.9 (1.3-6.9)  
   At least 4 days' total exposure   17   9   26   3   3.0   2.1 (1.0-4.4)  
DDT  5   3   4   0.5   5.5  6.7 (1.5-30)  
   Applied by subject   5   3   4   0.5   5.5   —  
   At least 4 days' total exposure   5   3   4   0.5   5.5   —  
Carbamates§  8   4   3   0.4   12  7.4 (1.7-31)  
   Applied by subject   7   4   2   0.3   —   —  
   At least 4 days' total exposure   6   3   1   0.1   —   —  
Paraquat  12   7   24   3   2.2   2.3 (1.0-5.1)  
   Applied by subject   7   4   17   2   1.8   1.7 (0.6-4.7)  
   At least 4 days' total exposure   7   4   20   3   1.6   1.9 (0.7-4.9)  
Other occupational pesticides  11   6   32   4   1.5   1.0 (0.4-2.2)  
   Applied by subject   6   3   18   2   1.5   0.7 (0.2-2.2)  
   At least 4 days' total exposure   9   5   24   3   1.6   1.1 (0.4-2.7)  
Any household pesticides
 
64
 
36
 
238
 
31
 
1.2
 
1.3 (0.9-1.9)
 

— indicates not calculated.

*

Relative to nonexposure to the pesticide under consideration

The following factors were included in the model: age, sex, residential location, year of interview (continuous term), pesticide use, exposure to ducks, animal fertilizer use, consumption of nonbottled water. Statistically significant estimates are italicized

Methyl parathion (19 cases, 32 controls), omethoate (1 case), methalamidophos (1 case)

§

Methomyl (6 cases, 1 control), carbofuran (2, 2), carbaryl (1, 0)

Glyphosate (3 cases, 23 controls), karate (3, 0), spark (1, 1), 2,4-D (1, 1), spato (1, 0), filatan (1, 0), supercorn (1, 0), endrin (0, 1), unspecified insecticide (2, 9), unspecified rodenticide (2, 1), unspecified fungicide (0, 1), unspecified herbicide (0, 1)

Farm animals, fertilizers, and other farming practices (phase 2, Khonkaen)

Farming practices were examined in phase 2 because the incidence of AA previously had been found to be higher in Khonkaen than in Bangkok and because we observed an association with rice farming. Here the analysis was confined to Khonkaen farmers and their families. There was no evidence of association for exposure to cattle, water buffalo, or chickens (Table 6). For exposure to ducks or geese, the relative risk estimate was 3.7 (1.6-8.1). For exposure to pigs, the point estimate was 2.5 but nonsignificant. More detailed information concerning the amount of care and number of animals maintained was unrevealing, as no material relationships were observed across categories of these factors (data not shown); in particular, the estimate for keeping at least 10 ducks was 3.9. For the use of animal fertilizers, the relative risk estimate was 2.1 (1.0-4.4), while for chemical fertilizers the prevalence of exposure was similar in cases and controls. Although there was not a clear relationship with type of animal fertilizer, more cases than controls used duck or pig waste.

Table 6.

Exposure to animals and fertilizers among farmers in Khonkaen (phase 2 data only)



Cases

Controls

Relative risk estimate*
Exposure
No.
%
No.
%
Crude
Multivariate(95% CI)
Farm animals       
   Cattle or water buffalo   30   45   79   33   1.7   1.2 (0.6-2.4)  
   Chickens   29   44   68   29   2.0   1.0 (0.5-2.0)  
   Ducks or geese  17   26   18   8   4.2  3.7 (1.6-8.1)  
   Pigs   5   8   5   2   3.8   2.5 (0.6-10)  
Fertilizer§       
   Chemical   46   70   161   68   1.1   —  
   Animal  18   27   30   13   2.6   2.1 (1.0-4.4)  
   Compost
 
0
 
0
 
1
 
0.4
 

 

 


Cases

Controls

Relative risk estimate*
Exposure
No.
%
No.
%
Crude
Multivariate(95% CI)
Farm animals       
   Cattle or water buffalo   30   45   79   33   1.7   1.2 (0.6-2.4)  
   Chickens   29   44   68   29   2.0   1.0 (0.5-2.0)  
   Ducks or geese  17   26   18   8   4.2  3.7 (1.6-8.1)  
   Pigs   5   8   5   2   3.8   2.5 (0.6-10)  
Fertilizer§       
   Chemical   46   70   161   68   1.1   —  
   Animal  18   27   30   13   2.6   2.1 (1.0-4.4)  
   Compost
 
0
 
0
 
1
 
0.4
 

 

 

Questions added in March, 1998; information available for 66 cases and 238 controls.

— indicates not calculated.

*

Relative to nonexposure to the factor under consideration

The following factors were included in the model: age, sex, residential location, year of interview (continuous term), pesticide use, exposure to farm animals, animal fertilizer use, consumption of nonbottled water. Statistically significant estimates are italicized

At least 10 ducks were kept by 11 cases and 10 controls (MVRR 3.9, 1.4-11)

§

No subjects reported using human waste as fertilizer

Cattle or water buffalo (15 cases, 24 controls; 1 case and 1 control did not report exposure to farm animals), chickens (5, 11); ducks (4, 3); pigs (3, 2)

Other farming practices and dietary habits among farmers also were examined. There were no statistically significant elevations in risk for eating raw (point estimate 2.0, 95% CI, 0.7-5.9; 7 cases, 10 controls), cooked, fermented, or salted crabs and fish obtained from the fields (data not shown). Other practices evaluated and also not found to be associated included eating rats from the field and type of footwear used (almost entirely barefoot or sandals) (data not shown). We also evaluated specific types of farming based on crop, and there was considerable overlap. There were adequate data for risk estimates for rice, cassava, and sugarcane only. Rice was predominant, and the overall relative risk estimate was 0.6 (0.4-1.0; 77 exposed cases, 300 exposed controls), in contrast to the positive association that we observed in phase 1, based on less-detailed information.35  For cassava, the relative risk was 4.5 (1.8-11; 13 cases, 13 controls). For sugarcane (8 exposed cases, 29 exposed controls; crude relative risk estimate, 1.2), there was no association. For other individual crops the data were scanty, with no more than 4 cases in each group.

Water and sanitary facilities (phase 2)

Sources of drinking water were identified in phase 2. Findings differed for Bangkok and Khonkaen and are presented separately (Table 7). In Bangkok, relative to the use of bottled or distilled water only, drinking water from other sources carried a relative risk of 1.0 (0.6-1.8), and there were no significant associations with specific sources. In Khonkaen, most cases and controls obtained drinking water from nonbottled sources; compared with those who drank bottled or distilled water only, the relative risk estimate was 2.8 (1.3-5.9), and it was even higher when income also was included in the model (3.3). The point estimates for specific sources of nonbottled water ranged from 2.6 to 3.8, all statistically significant. In both Bangkok and Khonkaen, more than 90% of cases and controls reported use of flush toilets with septic tanks, and there were no significant associations with AA (data not shown).

Table 7.

Sources of drinking water among 257 cases of aplastic anemia and 1087 controls according to region; phase 2 data only



Cases

Controls

Relatie risk estimate
Source
No.
%
No.
%
Crude
Multivariate*(95% CI)
Bangkok; 77 cases, 317 controls       
   Bottled/distilled water only   25   32   102   32   1.0  1.0 
   Other sources§   52   68   215   68   1.0   1.0 (0.6-1.8)  
      Well water   2   3   1   0.3   —   —  
      Tap water   10   13   55   17   0.7   0.8 (0.3-1.7)  
      Rain water   3   4   24   8   0.5   0.5 (0.1-1.9)  
      Boiled water   28   36   82   26   1.4   1.6 (0.8-3.2)  
      Other   5   6   13   4   1.6   1.7 (0.5-5.2)  
Khonkaen; 180 cases, 770 controls       
   Bottled/distilled water only   9   5   115   15    1.0 
   Other sources  171   95   655   85   3.3  2.8 (1.3-5.9)  
      Well water   18   10   42   5   5.5  3.5 (1.4-9.2)  
      Nonartesian water only   13   7   26   3   6.4  3.7 (1.3-11)  
      Tap water   8   4   25   3   4.1  3.8 (1.2-12)  
      Rain water   141   78   563   73   3.2  2.6 (1.2-5.6)  
      Boiled water   15   8   50   6   3.8  2.9 (1.1-7.7)  
      Other
 
2
 
1
 
16
 
2
 

 

 


Cases

Controls

Relatie risk estimate
Source
No.
%
No.
%
Crude
Multivariate*(95% CI)
Bangkok; 77 cases, 317 controls       
   Bottled/distilled water only   25   32   102   32   1.0  1.0 
   Other sources§   52   68   215   68   1.0   1.0 (0.6-1.8)  
      Well water   2   3   1   0.3   —   —  
      Tap water   10   13   55   17   0.7   0.8 (0.3-1.7)  
      Rain water   3   4   24   8   0.5   0.5 (0.1-1.9)  
      Boiled water   28   36   82   26   1.4   1.6 (0.8-3.2)  
      Other   5   6   13   4   1.6   1.7 (0.5-5.2)  
Khonkaen; 180 cases, 770 controls       
   Bottled/distilled water only   9   5   115   15    1.0 
   Other sources  171   95   655   85   3.3  2.8 (1.3-5.9)  
      Well water   18   10   42   5   5.5  3.5 (1.4-9.2)  
      Nonartesian water only   13   7   26   3   6.4  3.7 (1.3-11)  
      Tap water   8   4   25   3   4.1  3.8 (1.2-12)  
      Rain water   141   78   563   73   3.2  2.6 (1.2-5.6)  
      Boiled water   15   8   50   6   3.8  2.9 (1.1-7.7)  
      Other
 
2
 
1
 
16
 
2
 

 

 

— indicates not calculated.

*

The following factors were included in the models: Bangkok: age, sex, year of interview (continuous term), consumption of nonbottled water; Khonkaen: age, sex, residential location, year of interview (continuous term), pesticide use, exposure to ducks, animal fertilizer use, consumption of nonbottled water. Statistically significant estimates are italicized

Reference category

Categories not mutually exclusive

Needles (phase 2)

Nonmedical needle exposures (tattoos, body piercing, and acupuncture) were examined in phase 2. Only 8 cases and 10 controls reported exposure, but the overall relative risk estimate was 3.8 (1.5-10). No information was requested on intravenous drug use or HIV infection.

Hepatitis and other diseases (total study data)

Medical history of hepatitis and jaundice, tuberculosis, rheumatoid arthritis, malaria, and worms in the stool was obtained throughout the course of the study. There were no significant associations (data not shown). In the combined data from phases 1 and 2, there were only 2 cases (< 1%) of apparent posthepatitis AA.

Evidence for a higher rate of AA in Asian countries than in the West has come from diverse sources, not all of equal reliability, and formal epidemiologic studies have been undertaken only recently. The IAAAS established a widely accepted annual incidence of 2 per million for Europe and Israel26 ; similar figures were obtained elsewhere in Europe.35-37  In the first phase of the present study, based on similar methodology to the IAAAS, we determined a stable rate of 3.9 per million for the Bangkok metropolitan area and in Khonkaen, 5 per million.27  Other Asian series have produced a range of 5 to 7 per million.38  Marked variations in the frequency of the disease, sometimes even within the same country or region, are suggestive of environmental factors influencing the occurrence of AA.

The salient findings in this study were associations of AA with a number of known or strongly suspected risk factors, and associations with some environmental factors not previously linked to the disease. Relative risk estimates ranged from 2.0 to 7.4. Previously reported factors included benzene and other solvents, pesticides, and certain specific drugs, including sulfonamides, mebendazole, and thiazides. For chloramphenicol, the data were sparse, and the point estimate was modestly elevated but not statistically significant. Factors that had not been reported previously included exposure to ducks and geese, the use of animal fertilizers among farmers, and nonmedical use of needles. We also observed a marked increased risk associated with use of nonbottled water in the Khonkaen region. Finally, there was a strikingly infrequent occurrence of posthepatitis AA.

In contrast to our previous report from phase 1 of the study,29  low income was no longer associated with AA. Inadequate control for confounding could have explained the relationship observed earlier; alternatively, low income may have initially reflected causal exposures, which changed over time. The latter possibility is plausible because there was considerable economic development in Thailand during the study period.

The positive association with benzene was anticipated, although few cases related a history of exposure. Marrow failure has been detected readily among Italian shoe workers in the 1950s39  and Chinese workers in a variety of industries in the 1960s.40,41  While industrial use of benzene has long been linked to bone marrow failure, the historical nature of the record and the recognition of other hematologic sequelae of chronic exposure has cast doubts on the accuracy of the early descriptions.42  Mild blood count abnormalities occur with benzene exposure43  and may have been incorrectly equated with AA in some surveys.44-46  While several decades ago benzene exposure appeared to account for a large proportion of AA causation in certain regions,47,48  it does not appear as a major risk factor in more recent population surveys or in clinic series. In the IAAAS, only about 5% of cases reported benzene exposure and another 3% petrochemical exposure, and benzene therefore was only a borderline risk factor.26  Chemical exposure was a risk factor in the French epidemiologic report.49  A recently published analysis of Chinese workers has suggested that even low levels of benzene can induce hematotoxicity.50 

We did not observe a convincing association between AA and exposure to specific solvents other than benzene, despite a questionnaire designed to elicit such details. However, the risk estimate was significantly elevated for overall exposure to solvents other than benzene, glues, and fuels, mostly to unspecified thinners. Turpentine was the chemical most frequently mentioned, but any possible association was confined to fewer than 4 days of cumulative exposure. We consider it improbable that a true causal association would not also be present for more substantial exposure. Despite early case reports implicating a variety of chemicals in the causation of AA, the limited numbers of population-based studies have not confirmed the clinical literature for such diverse agents as hair dyes,51  glycol ethers,52  or Stoddard's solvent.53  In a recent study of environmental factors performed in the United Kingdom, exposure to solvents and degreasing agents was common among both cases and controls, but showed only a borderline association with AA.54 

In the Khonkaen region, we observed significant associations with several pesticides, including organophosphates, DDT, and carbamates, and a borderline association with paraquat. In the IAAAS, occupational insecticide use also was a risk factor for AA (overall relative risk, 3.7), although relatively few patients had been exposed (5% of cases compared to 2% of controls).26  Lack of evidence of an association with household pesticide exposure in the present study may indicate a dose relationship, but different chemical formulations often are employed for home compared to agricultural use. Other epidemiologic data concerning pesticide exposure and AA are weak. There are large numbers of patient histories anecdotally relating AA to pesticides.55  The British case-control study identified an overall 2.5-fold increase in risk with occupational exposure, but specific pesticides were not evaluated. There also was a 5-fold increase in risk among adults whose homes were treated for woodworm.54  Individual pesticides have been implicated in disease causation, including, particularly, the chlorinated hydrocarbons, organophosphates, chlorophenols, and pyrethins.56-59  Agricultural carbamates have not been associated previously with AA. We reported a possible association with household insecticides in this class from phase 1 of the present study31  that was not observed in the phase 2 data. Dose-related toxicity has not been supported by surveys of individuals most likely to be heavily exposed, including manufacturers,60-63  applicators,64-67  or farm workers,68,69  with only rare exceptions.70,71 

Of all drugs, chloramphenicol has been the agent most prominently associated with AA.2,72,73  In the 1950s and following decades, the drug was considered to be the most common cause of the disease.74,75  In the current study, chloramphenicol was infrequently used and there was no significant association; however, the numbers were insufficient to exclude an increased risk. Earlier studies suggesting that chloramphenicol increases the risk of AA have been criticized. Almost certainly, the evidence from adverse reaction report registries was biased by a selective tendency to report exposed cases, and the earlier epidemiologic studies were methodologically unsatisfactory. Chloramphenicol is inexpensive and effective and continues to be a popular drug in certain parts of the world. Based on the present findings, we concur with the view that the risk of AA in chloramphenicol users was probably overstated in the past.

For other drugs, the present findings resemble those described in phase 1,32  but for sulfonamides, mebendazole, and thiazides, the relative risk point estimates based on the full data, while significantly elevated, were all lower. For NSAIDs, the relative risk estimate of 1.6 was compatible with some very modest increase in risk but nonsignificant. In the IAAAS,26  sulfonamide use was associated with AA, and the use of thiazide diuretics was not, and there was no mebendazole use; several NSAIDs were significantly associated with AA. The presently identified associations with sulfonamides, thiazide diuretics, and mebendazole can, at most, account only for a small proportion of the occurrence.

Several of the novel risk factors identified in the current study of AA, especially the farm exposures to ducks and geese, animals that can serve as zoonotic reservoirs for viruses, and the consumption in Khonkaen of water from nonbottled sources, which could account for most cases there, are suggestive of exposure to an infectious agent. Alternative explanations for the association with nonbottled water also should be noted, including chemical contamination of water supplies and unidentified lifestyle factors that could not be allowed for in the analysis. The potential relationships with the use of animal fertilizers and nonmedical needle exposures provide further evidence for an infectious etiology, which has been suspected for AA on several grounds. Clinically, marrow failure can represent a rare but serious sequela of certain specific infections, especially following Epstein-Barr virus infection and infectious mononucleosis76  and after seronegative hepatitis.77  Postviral AA is responsive to immunosuppressive drugs, consistent with an immune mechanism of marrow cell destruction78 ; indeed, the involvement of activated cytotoxic lymphocytes and cytokines is the normal pattern of the immune response to a large variety of viral agents. Many other autoimmune diseases have postulated but unknown infectious triggers. Some of the chemicals and drugs historically associated with AA on the assumption of direct toxicity for hematopoietic cells might be surrogates for infectious exposure: pesticides for an insect vector and chloramphenicol or NSAIDs for a preceding febrile illness are examples. In the first epidemiologic study of AA, an American medical officer at the end of World War II noted the surprisingly large number of cases of AA among soldiers serving in the Pacific (6.6-28.4/million) compared to numbers reported for those elsewhere (0.4 to 1.8/million).79  While Custer blamed this enormous difference on atabrine malaria prophylaxis, this agent has been linked to only a handful of cases of AA; equally plausible is the possibility of exposure of a naive group to an endemic, geographically limited agent.

Posthepatitis AA syndrome accounts for about 10% of marrow failure in Western case series.77,80  Strikingly, in the current study, hepatitis was virtually absent in the medical history of cases in Thailand. This observation is particularly puzzling, as acute seronegative hepatitis (non-A, non-B, non-C, non-E) is far more frequent in Asian hepatology clinics, where it may represent approximately 20% of cases,81  than in the West, where the frequency is only a few percentage points.82  Differences in host response may be linked to the immune system, as HLA B8, strongly associated with posthepatitis AA among American patients,83  is a rare histocompatability antigen in Asian populations.

The overall validity of the present findings must be interpreted in the light of the following considerations: first, some identified associations are based on small numbers, and statistical significance notwithstanding, may be fragile and susceptible to error due to misclassification. The identification of organic solvents, a large proportion of which could not be specified by the subjects, or individual pesticides, for example, sometimes could be mistaken. When numbers were large, random misclassification or under-reporting would generally result in attenuation of the magnitude of the observed associations, but when the numbers were small, that assumption may not hold even for relatively large relative risk point estimates, and they must be interpreted cautiously. The possibility that misclassification or under-reporting, particularly for occupational exposures that might not be recognized by subjects, could have resulted in failure to identify some associations also must be considered. For solvent and pesticide exposures, in general, risk estimates for higher cumulative exposure were similar to the overall risk estimates; while possibly indicating misreporting of the amounts of exposure, a dose-response might not be evident due to the small numbers of exposed subjects or to the presence of a (low) threshold effect.

Second, some apparent associations could have been due to bias or confounding. Information bias could have occurred if the interviewers or the subjects, especially the cases, were aware that substances such as benzene or other chemicals may cause AA. All subjects were interviewed shortly after hospital admission (the median interval was 3 days for cases and 2 days for controls), and the interviews and questionnaires were highly structured, rendering information bias less likely but impossible to exclude completely.

Selection bias was generally unlikely. Bias due to refusal to participate was not present: there were no refusals. With regard to the identification of the cases, the definition of AA was standardized and rigorous: virtually all cases were prospectively identified, and the study was population based except in Bangkok, phase 2, where selection bias could have occurred if cases admitted to Siriraj Hospital differed in their exposure status from cases admitted to other hospitals. Bias in the selection of controls was improbable because subjects were eligible for inclusion only if they were admitted for conditions unlikely to be related to putatively causal agents.

Allowance was made for potential confounding by several factors, including age, sex, residence, year of interview, and exposures associated in this study with AA (such as various pesticides) or identified as possible causes in the literature (such as benzene). Nevertheless, since it is possible that many of the environmental causes of AA remain unknown, residual confounding by unidentified factors cannot be ruled out. In addition, when numbers of exposed subjects were small, the multivariate models used in the analysis may have been unstable, and adjustment for confounding may have been inadequate.

Etiologic fractions are shown in Table 8 for all factors that were significantly associated, based on relative risk estimates reported in “Results.” Previously suspected risk factors accounted for only a small proportion of the occurrence of AA in Thailand, especially in comparison to Western series. None of the agents implicated historically—benzene, chloramphenicol, and other drugs—could explain the higher rate of marrow failure that we observed. Novel factors—water source, animal exposure, use of animal fertilizers, and nonmedical needle exposures—could account for a large proportion of cases in Khonkaen, and point to an infectious etiology. Pesticides, which may themselves be toxic to marrow, might also represent surrogates for an infectious exposure, as through an insect vector. In addition, these factors may partly explain the higher incidence of AA in rural Khonkaen compared to Bangkok, and possibly also the high incidence in Asia compared to the West. The findings also suggest future research to identify a putative infectious agent as well as genetic risk factors for disease and the use of molecular laboratory assays in the context of population-based studies.

Table 8.

Etiologic fractions for various factors associated with aplastic anemia in Thailand


Factor

Relative risk estimate

Proportion of cases exposed, %

Etiologic fraction, %
Benzene   3.5   1   1  
Other organic solvents*  2.0   11   5  
Associated drugs  3.9   4   3  
Agricultural pesticides (Khonkaen)  3.5   22   15  
Exposure to ducks (Khonkaen)§  3.7   26   19  
Use of animal fertilizers (Khonkaen)§  2.1   27   14  
Use of nonbottled water (Khonkaen)   2.8   95   61  
Nonmedical needle exposures
 
3.8
 
3
 
2
 

Factor

Relative risk estimate

Proportion of cases exposed, %

Etiologic fraction, %
Benzene   3.5   1   1  
Other organic solvents*  2.0   11   5  
Associated drugs  3.9   4   3  
Agricultural pesticides (Khonkaen)  3.5   22   15  
Exposure to ducks (Khonkaen)§  3.7   26   19  
Use of animal fertilizers (Khonkaen)§  2.1   27   14  
Use of nonbottled water (Khonkaen)   2.8   95   61  
Nonmedical needle exposures
 
3.8
 
3
 
2
 

Based on all factors with elevated relative risk estimates and lower confidence limits of 1.0 or greater that represent direct exposures (Results; Tables 3, 4, 5, 6, 7). The factors are not mutually exclusive, and therefore the individual etiologic fractions cannot be summed to determine the total proportion of aplastic anemia that can be explained.

*

Not including fuels or glues

Sulfonamides, mebendazole, and thiazide diuretics

Organophosphates, DDT, carbamates, paraquat

§

Among farmers, farm workers, or those who live on farms

Members of the Aplastic Anemia Study Group include A. Piankijagum, T. Thamprasit, S. Vannasaeng, Y. Porapakham, C. Sriratanasatavorn, C. Yamcharoen, S. Kittimongcolporn, P. Liewsiri, S. Sompradeekul, T. Vuttivatanakul, K. Tepmongkol, S. Jiraprayuklert, Y. Jiratanyasakul, R. Stitmetakul, V. Kittilucksanon, W. Deechakawan, S. Ratanawongvej, S. Leelasoontornwatana, Y. Somboonwanna, R. Wongkongdej, R. Vejjapinand, V. Kiatvirakul, K. Karang, S. Ninaek, S. Soonporai, B. Chatchawan, T. Intragumtornchai, S. Chancharunee, V. Chinarat, W. Prayoonwiwat, A. Chuansamrit, V. Suvatte, J. Sirijirachai, D. Sonakul, and S. Sukpanichnand.

Prepublished online as Blood First Edition Paper, October 27, 2005; DOI 10.1182/blood-2005-01-0161.

Supported by grant number HL 35068 from the National Heart, Lung, and Blood Institute.

An Inside Blood analysis of this article appears at the front of this issue.

The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 U.S.C. section 1734.

We thank John Farrell for designing the database and computer programs for the study.

1
Young NS. Acquired aplastic anemia.
Ann Intern Med
.
2002
;
136
:
534
-546.
2
Young NS. Drugs and chemicals. In: Young NS, Alter BP, eds.
Aplastic Anemia, Acquired and Inherited
. Philadelphia, PA: WB Saunders;
1994
:
100
-132.
3
Young NS. Viruses as agents of marrow failure. In: Young NS, Alter BP, eds.
Aplastic Anemia, Acquired and Inherited
. Philadelphia, PA: WB Saunders;
1994
:
133
-158.
4
Choudhry VP, Gupta S, Gupta M, Kashyap R, Saxena R. Pregnancy associated aplastic anemia—a series of 10 cases with review of literature.
Hematology
.
2002
;
7
:
233
-238.
5
Cartwright RA, McKinney PA, Williams L, et al. Aplastic anaemic incidence in parts of the United Kingdom in 1985.
Leuk Res
.
1988
;
12
:
459
-463.
6
Linet MS, Tielsch JM, Markowitz JA, et al. An apparent cluster of aplastic anemia in a small population of teenagers.
Arch Intern Med
.
1985
;
145
:
635
-640.
7
Morgan GJ, Palmer SR, Onions D, et al. A cluster of three cases of aplastic anaemia in children.
Clin Lab Haematol
.
1988
;
10
:
29
-32.
8
Whang KS. Aplastic anemia in Korea: a clinical study of 309 cases. In: Hibino S, Takaku F, Shahidi NT, eds.
Aplastic Anemia
. Baltimore, MD: University Park Press;
1978
:
225
-242.
9
Bernard J. Esquisse d'une hèmatologie gèographique.
Nouv Rev Fr Hematol
.
1963
;
3
:
51
-58.
10
Dameshek W. Riddle: What do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and “hypoplastic” leukemia have in common?
Blood
.
1967
;
30
:
251
-254.
11
Böttiger LE, Böttiger B. Incidence and cause of aplastic anemia, hemolytic anemia, agranulocytosis and thrombocytopenia.
Acta Med Scand
.
1981
;
210
:
475
-479.
12
Wang S, Guo N, Lu D. Analysis of 181 cases of adult acquired aplastic anemia.
J Beijing Med College
.
1981
;
13
:
172
-175.
13
Lee CH, Chai ES. Aplastic anemia: an analysis of 349 cases in Korea.
Korean J Hematol
.
1966
;
1
:
3
-20.
14
Chuansumrit A, Hathirat P, Isarangkura P. Acquired aplastic anemia in children: a review of 100 patients. Southeast Asian J Trop.
Med Public Health
.
1990
;
21
:
313
-320.
15
Chatterjea JB, Swarup S, Ghosh SK, Banerjee DK. Observations on acquired aplastic anaemia.
J Indian Med Assoc
.
1961
;
37
:
536
-540.
16
Khosla SN, Chopra JS, Arora BS. Aplastic anaemia: a clinical study.
J Assoc Physicians India
.
1972
;
20
:
745
-749.
17
Hassan K, Ikram N, Akhtar MJ, et al. Severe aplastic anaemia—an aetiological correlation.
JPMA J Pak Med Assoc
.
1994
;
44
:
43
-45.
18
Banihashemi A, Kohout E, Hedayatee H. Aplastic anemia in Shiraz, an analysis of 50 cases with special reference to etiological agents in Southwest Iran.
Blut
.
1973
;
26
:
20
-26.
19
Al-Mondhiry HA. Aplastic anaemia in Iraq: a prospective study.
Haematologica
.
1979
;
12
:
159
-164.
20
Aoki K, Ohno Y, Mizuno S, Sasaki R. Epidemiological aspects of aplastic anemia.
Acta Haematol Jpn
.
1981
;
44
:
44
-53.
21
Böttiger LE. Epidemiology and aetiology of aplastic anemia.
Haematol Bluttransfus
.
1979
;
24
:
27
-37.
22
Corrigan GE. An autopsy survey of aplastic anemia.
Am J Clin Pathol
.
1974
;
62
:
488
-490.
23
Yin D, Wu Y, Lin Z, Meng Q, Kang J. Epidemiological and etiological studies on aplastic anemia in the Mudanjiang area: Chung-Hua Hsueh Yeh Hsueh Tsa Chih.
Chinese J Hematol
.
1980
;
1
:
33
-34.
24
Shima S, Kato Y, Tachikawa S, et al. Aplastic anemia and occupational factors in Japanese industries.
Sanyo Igaku
.
1987
;
29
:
116
-129.
25
Kumana CR, Li KY, Kou M. Do chloramphenicol blood dyscrasias occur in Hong Kong?
Adverse Drug React Toxicol Rev
.
1993
;
12
:
97
-106.
26
Kaufman DW, Kelly JP, Levy M, Shapiro S.
The Drug Etiology of Agranulocytosis and Aplastic Anemia
. New York, NY: Oxford University Press;
1991
.
27
Issaragrisil S, Leaverton PE, Chansung K, et al. Regional patterns in the incidence of aplastic anemia in Thailand.
Am J Hematol
.
1999
;
61
:
164
-168.
28
Issaragrisil S, Sriratanasatavorn C, Piankijagum A, et al. The incidence of aplastic anemia in Bangkok.
Blood
.
1991
;
77
:
2166
-2168.
29
Issaragrisil S, Kaufman D, Anderson T, et al. An association of aplastic anaemia in Thailand with low socioeconomic status.
Br J Haematol
.
1995
;
91
:
80
-84.
30
Issaragrisil S, Chansung K, Kaufman DW, et al. Aplastic anemia in rural Thailand: its association with grain farming and agricultural pesticide use.
Am J Public Health
.
1997
;
87
:
1551
-1554.
31
Kaufman DW, Issaragrisil S, Anderson T, et al. Use of household pesticides and the risk of aplastic anaemia in Thailand.
Int J Epidemiol
.
1997
;
26
:
643
-650.
32
Issaragrisil S, Kaufman DW, Anderson TE, et al. Low drug attributability of aplastic anemia in Thailand.
Blood
.
1997
;
89
:
4034
-4039.
33
Schlesselman JJ.
Case-control Studies: Design, Conduct, Analysis
. New York, NY: Oxford University Press;
1982
.
34
Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait, or intervention.
Am J Epidemiol
.
1974
;
99
:
325
-332.
35
Tweddle DA, Reid MM. Aplastic anemia in the Northern Region of England [letter].
Acta Paediatr
.
1996
;
85
:
1388
-1389.
36
Mary JY, Baumelou E, Guiguet M. Epidemiology of aplastic anemia in France: a prospective multicenter study.
Blood
.
1990
;
75
:
1646
-1653.
37
Clausen N, Kreuger A, Salmi T, Storm-Mathisen I, Johannesson G. Severe aplastic anaemia in the Nordic countries: a population based study of incidence, presentation, course, and outcome.
Arch Dis Child
.
1996
;
74
:
319
-322.
38
Yong AS, Goh M, Rahman J, Menon V, Purushothaman V. Epidemiology of aplastic anemia in the state of Sabah, Malaysia.
Cell Immunol
.
1996
;
1284
:
75
.
39
Paci E, Buiatti E, Costantini AS, et al. Aplastic anemia, leukemia and other cancer mortality in a cohort of shoe workers exposed to benzene.
Scand J Work Environ Health
.
1989
;
15
:
313
-318.
40
Yin S-N, Hayes RB, Linet MS, et al. A cohort study of cancer among benzene-exposed workers in China: overall results.
Am J Ind Med
.
1996
;
29
:
227
-235.
41
Yin S-N, Li Q, Liu Y, et al. Occupational exposure to benzene in China.
Br J Ind Med
.
1987
;
44
:
192
-195.
42
Dipple A, Pigott MA, Agarwal SK, et al. Optically active benzo [c] phenanthrene diol epoxides bind extensively to adenine in DNA.
Nature
.
1987
;
327
:
535
-536.
43
Rothman N, Li GL, Dosemeci M, et al. Hematoxicity among Chinese workers heavily exposed to benzene.
Am J Ind Med
.
1999
;
29
:
236
-246.
44
Aksoy M, Erdem S. Followup study on the mortality and the development of leukemia in 44 pancytopenic patients with chronic exposure to benzene.
Blood
.
1978
;
52
:
285
-291.
45
Kipen HM, Cody RP, Crump KS, Allen BC, Goldstein BD. Hematologic effects of benzene: a thirty-five year longitudinal study of rubber workers.
Toxicol Ind Health
.
1988
;
4
:
411
-430.
46
Truhaut R, Murray R. International workshop on toxicology of benzene, Paris: 9th-11th November 1976.
Int Arch Occup Environ Health
.
1978
;
41
:
65
-76.
47
Vigliani EC, Saita G. Benzene and leukemia.
N Engl J Med
.
1964
;
271
:
872
-876.
48
Aksoy M, Erdem S, Dincol G, Bakioglu I, Kutlar A. Aplastic anemia due to chemicals and drugs: a study of 108 patients.
Sex Transm Dis
.
1984
;
11
:
347
-350.
49
Mary JY, Guiguet M, Baumelou E. French Cooperative Group. Drug use and aplastic anaemia: the French experience.
Eur J Haematol
.
1996
;
57
:
35
-41.
50
Lan Q, Zhang L, Li G, et al. Hematotoxicity in workers exposed to low levels of benzene.
Science
.
2004
;
306
:
1774
-1780.
51
Shibata A, Sasaki R, Hamajima N, Aoki K. Mortality of hematopoietic disorders and hair dye use among barbers.
Acta Haematol Jpn
.
1990
;
53
:
116
-118.
52
Cullen MR, Rado T, Waldron JA, Sparer J, Welch LS. Bone marrow injury in lithographers exposed to glycol ethers and organic solvents used in multicolor offset and ultraviolet curing printing processes.
Arch Environ Health
.
1983
;
38
:
247
-354.
53
Sciences International
. Toxicological Profile for Stoddard Solvent: U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry;
1995
.
54
Muir KR, Chilvers CE, Harriss C, et al. The role of occupational and environmental exposures in the aetiology of acquired severe aplastic anaemia: a case control investigation.
Br J Haematol
.
2003
;
123
:
906
-914.
55
Fleming LE, Timmeny W. Aplastic anemia and pesticides: an etiologic association?
J Occup Med
.
1993
;
35
:
1106
-1116.
56
Sánchez-Medal L, Castanedo JP, Garcia-Rojas F. Insecticides and aplastic anemia.
N Engl J Med
.
1963
;
269
:
1365
-1367.
57
West I. Lindane and hematologic reactions.
Arch Environ Health
.
1967
;
15
:
97
-101.
58
Stormont RT. The present status of chlordane.
JAMA
.
1955
;
158
:
1364
-1367.
59
Stormont RT. Pharmacologic and toxicologic aspects of DDT (chlorophenothane U.S.P.).
JAMA
.
1951
;
135
:
728
-733.
60
Alvarez WC, Hyman S. Absence of toxic manifestations in workers exposed to chlordane.
Arch Ind Hyg Occup Med
.
1953
;
8
:
480
-483.
61
Princi F, Spurbeck GH. A study of workers exposed to the insecticides chlordan, aldrin, dieldrin.
Arch Ind Hyg Occup Med
.
1951
;
3
:
64
-72.
62
Sutton JF, Stacey M, Kearsey SE, et al. Increased risk for aplastic anemia and myelodysplastic syndrome in individuals lacking GSTT1 gene.
Pediatric Blood Cancer
.
2004
;
42
:
122
-126.
63
Wang HH, MacMahon B. Mortality of workers employed in the manufacture of chlordane and heptachlor.
J Occup Med
.
1979
;
21
:
745
-748.
64
Blair A, Grauman DJ, Lubin JH, Fraumeni JF. Lung cancer and other causes of death among licensed pesticide applicators.
J Natl Cancer Inst
.
1983
;
71
:
31
-37.
65
Samuels AJ, Milby TH. Human exposure to lindane: clinical, hematological and biochemical effects.
J Occup Med
.
1971
;
13
:
147
-151.
66
Stein WJ, Hayes WJ. Health survey of pest control operators.
IMS Ind Med Surg
.
1964
;
33
:
549
-555.
67
Wang HH, MacMahon B. Mortality of pesticide applicators.
J Occup Med
.
1979
;
21
:
741
-744.
68
Rappolt RT. Kern county pesticide study.
IMS Ind Med Surg
.
1970
;
39
:
40
-44.
69
Wang HH, Grufferman S. Aplastic anemia and occupational pesticide exposure: a case-control study.
J Occup Med
.
1981
;
23
:
364
-366.
70
Gallagher RP, Threlfall WJ, Jeffries E, et al. Cancer and aplastic anemia in British Columbia farmers.
J Natl Cancer Inst
.
1984
;
72
:
1311
-1315.
71
Davignon LF, St-Pierre J, Charest G, Tourangeau FJ. A study of the chronic effects of insecticides in man.
CMAJ
.
1965
;
92
:
597
-602.
72
Yunis AA. Chloramphenicol toxicity: 25 years of research.
Am J Med
.
1989
;
87
:
44N
-48N.
73
Trevett AJ, Naraqi S. Saint or sinner? A look at chloramphenicol.
PNG Med J
.
1992
;
35
:
210
-216.
74
Council on Drugs. Registry on blood dyscrasias (Report to the Council).
JAMA
.
1962
;
179
:
888
-890.
75
Polak BC, Wesseling H, Schut D, Herxheimer A, Meyler L. Blood dyscrasias attributed to chloramphenicol.
Acta Med Scand
.
1972
;
192
:
409
-414.
76
Baranski B, Armstrong G, Truman JT, et al. Epstein-Barr virus in the bone marrow of patients with aplastic anemia.
Ann Intern Med
.
1988
;
109
:
695
-704.
77
Brown KE, Tisdale J, Dunbar CE, Young NS. Hepatitis-associated aplastic anemia.
N Engl J Med
.
1997
;
336
:
1059
-1064.
78
Young NS, Maciejewski J. The pathophysiology of acquired aplastic anemia.
N Engl J Med
.
1997
;
336
:
1365
-1372.
79
Custer RP. Aplastic anemia in soldiers treated with atabrine.
Am J Med Sci
.
1946
;
212
:
211
-224.
80
Safadi R, Or R, Ilan Y, et al. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation.
Bone Marrow Transplant
.
2001
;
27
:
183
-190.
81
Corwin AL, Dai TC, Duc DD, et al. Acute viral hepatitis in Hanoi, Viet Nam.
Trans R Soc Trop Med Hyg
.
1996
;
90
:
647
-648.
82
Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States.
N Engl J Med
.
1992
;
327
:
1899
-1905.
83
Brown KE, Tisdale J, Dunbar CE, Barrett AJ, Young NS. Hepatitis/aplastic anemia: an immune-mediated disease of unknown viral (?) etiology [abstract].
Blood
.
1996
;
88
:
309a
.
Sign in via your Institution